Zydelig (idelalisib)
pCPA File Number:
20875
Negotiation Status:
Negotiations were not pursued
Indication(s):
Relapsed or refractory follicular lymphoma
Sponsor/Manufacturer:
Gilead Sciences Canada Inc.
CADTH Project Number:
pCODR 10075
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: